2219 Stock Overview
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, engages in the provision of medical services and pharmaceuticals products in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
New Journey Health Technology Group Co.,LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.41 |
| 52 Week High | CN¥5.25 |
| 52 Week Low | CN¥1.97 |
| Beta | 0.36 |
| 1 Month Change | -2.43% |
| 3 Month Change | -10.41% |
| 1 Year Change | -49.90% |
| 3 Year Change | -28.27% |
| 5 Year Change | -30.75% |
| Change since IPO | 39.47% |
Recent News & Updates
Shareholder Returns
| 2219 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 7.6% | 1.7% | 2.1% |
| 1Y | -49.9% | -34.4% | -14.2% |
Return vs Industry: 002219 underperformed the CN Healthcare industry which returned -35.2% over the past year.
Return vs Market: 002219 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 2219 volatility | |
|---|---|
| 2219 Average Weekly Movement | 7.7% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002219 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002219's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 7,803 | n/a | www.njhtg.com |
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, engages in the provision of medical services and pharmaceuticals products in China and internationally. It operates regional medical centers, and tertiary and second-level hospitals. The company is also involved in the research and development, production, and sale of pharmaceutical products, including Duyiwei capsules and tablets, Shenqi Wuweizi tablets, Maiping tablets, Qianlie Antong tablets, and Gongliuning capsules.
New Journey Health Technology Group Co.,LTD Fundamentals Summary
| 2219 fundamental statistics | |
|---|---|
| Market cap | CN¥8.22b |
| Earnings (TTM) | CN¥33.43m |
| Revenue (TTM) | CN¥3.67b |
245.9x
P/E Ratio2.2x
P/S RatioIs 2219 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2219 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.67b |
| Cost of Revenue | CN¥2.57b |
| Gross Profit | CN¥1.09b |
| Other Expenses | CN¥1.06b |
| Earnings | CN¥33.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0098 |
| Gross Margin | 29.82% |
| Net Profit Margin | 0.91% |
| Debt/Equity Ratio | 73.7% |
How did 2219 perform over the long term?
See historical performance and comparison